TY - JOUR T1 - Treatment with ledipasvir-sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial JF - Ann Intern Med Y1 - 2017 A1 - Colombo, Massimo A1 - Aghemo, Alessio A1 - Liu, Hong A1 - Zhang, Jie A1 - Dvory-Sobol, Hadas A1 - Hyland, Robert A1 - Yun, Chohee A1 - Massetto, Benedetta A1 - Brainard, Diana M. A1 - McHutchison, John G. A1 - Bourliere, Marc A1 - Peck-Radosavljevic, Markus A1 - Manns, Michael A1 - Pol, Stanislas KW - Adult KW - Aged KW - Antiviral Agents KW - Benzimidazoles KW - Drug Administration Schedule KW - Drug Resistance, Viral KW - Drug Therapy, Combination KW - Female KW - Fluorenes KW - Genotype KW - Glomerular Filtration Rate KW - Hepatitis C, Chronic KW - Humans KW - Immunosuppressive Agents KW - Kidney Transplantation KW - Male KW - Middle Aged KW - sofosbuvir VL - 166 SP - 109-117 IS - 2 ER -